Medical cannabis is the largest emerging market in the United States, thus offering exciting opportunities for analytical testing, research and cannabinomics. One of our most heartfelt opinions is that the lack and outright prevention of cannabis research has resulted in millions of people left without potential treatment, and for some, death. It is on this same boat that we sail here at Cann-A-Lab that we strive to elucidate every potential medical benefic out of this amazing plant. For over 80 years the cannabis industry has been suppressed and now we have the chance to bounce back! We believe that the prohibition of cannabis has directly contributed to the opioid crisis in North America, and that cannabis should not be treated with the false stigma of being a ‘gateway drug’ and instead should be seen as an ‘exit drug’; a therapy that assists one to quit heavy drugs.
Cannabis contains over 400 unique compounds, each of which have unique properties and actions. It’s going to take some time before we completely understand all the synergies between cannabinoids, terpenoids, and flavonoids but now we have the opportunity to research cannabis in full, going above and beyond basic potency testing of THC, CBD, CBN, CBG etc. to discover the therapeutic values of terpenes and other molecules in the plant. Terpenes are a very important class of cannabis compounds, they are produced in cannabis trichromes and give cannabis its distinct smells and flavors. Terpenes also act as essential medicinal building blocks, influencing the overall homeopathic effect of the medicine. For example, Pinene gives cannabis its distinct pine odor and functions as a bronchodilator, opening the lungs to improve cannabinoid adsorption. Linalool imparts a floral aroma to cannabis and causes intense sedation as well as potential anti-cancer properties. Another terpene, Limonene, delivers a citrus smell to cannabis and provides potential anti-cancer, anti-bacterial, anti-fungal and anti-depression properties.
The roles of terpenes, as well as flavonoids, are becoming massively more important in understanding the cannabinoid synergies and overall therapeutic effects of cannabis. As such, we have identified that the next frontier for cannabis analytical testing and research resides in personalized cannabinomics. Cann-a-lab has a holistic approach to cannaceutical development, focusing on quality rather than yield, to produce blends of cannabis genetics in response to patient outcomes and tailoring personalized cannabinomics strategies for each individual patient. Cannabis produces different chemicals due to multiple environmental/ physical stresses and needs. As we learn more about the health benefits of cannabis, we must gain a much better understanding of the synergies of cannabinoids, terpenes and flavonoids. This represents a great opportunity for us analytical biochemists to offer concierge-style medicine and the potential to understand and unlock the interactions of cannabinomics on a larger, disease-specific scale. Taking it a step further, we strive to achieve fine-tuning of cannabis components for maximum therapeutic effect through research and analytical testing. We sincerely hope you can join us in our efforts to discover the true medicinal benefits of cannabis.